Strumento inattivo

Azioni Albany Molecular Research, Inc. Deutsche Boerse AG

Azioni

Durata

Periodo

Stile

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17/01/18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04/01/18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19/12/17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30/11/17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09/11/17

Dirigenti	Titolo	Età	Da
Philip W Macnabb CEO	Chief Executive Officer	-	01/05/23
Meera Khullar CMP	Compliance Officer	-	01/03/19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01/06/18

Amministratori	Titolo	Età	Da
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	-0,09%	42,12 Mrd
LONZA GROUP AG	+49,62%	42,05 Mrd
CELLTRION, INC.	-4,96%	29,18 Mrd
ICON PUBLIC LIMITED COMPANY	+11,18%	26,02 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,95%	18,9 Mrd
BIO-TECHNE CORPORATION	+8,61%	13,21 Mrd
UNITED THERAPEUTICS CORPORATION	+24,73%	12,17 Mrd
MEDPACE HOLDINGS, INC.	+28,31%	12,16 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6,26%	11,42 Mrd